SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-072706
Filing Date
2024-03-20
Accepted
2024-03-20 16:11:40
Documents
16
Period of Report
2024-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774533d8k.htm   iXBRL 8-K 36192
2 EX-1.1 d774533dex11.htm EX-1.1 172173
3 EX-5.1 d774533dex51.htm EX-5.1 12438
7 GRAPHIC g774533g0320085521236.jpg GRAPHIC 2213
  Complete submission text file 0001193125-24-072706.txt   404291

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20240318.xsd EX-101.SCH 2872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20240318_lab.xml EX-101.LAB 18758
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20240318_pre.xml EX-101.PRE 11725
19 EXTRACTED XBRL INSTANCE DOCUMENT d774533d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 24767902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)